Disc Medicine Stock Analysis

IRON Stock   64.48  1.09  1.66%   
Below is the normalized historical share price chart for Disc Medicine extending back to August 12, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Disc Medicine stands at 64.48, as last reported on the 19th of February, with the highest price reaching 66.83 and the lowest price hitting 63.76 during the day.
IPO Date
12th of August 2020
200 Day MA
67.8569
50 Day MA
80.6344
Beta
2.584
 
Covid
 
Interest Hikes
At this time, Disc Medicine's Total Debt To Capitalization is very stable compared to the past year. As of the 19th of February 2026, Debt Equity Ratio is likely to grow to 0.06, while Net Debt is likely to drop (153.5 M). With a high degree of financial leverage come high-interest payments, which usually reduce Disc Medicine's Earnings Per Share (EPS).
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.0694
Current Value
0.066
Quarterly Volatility
1.25813803
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
At this time, Disc Medicine's Total Stockholder Equity is very stable compared to the past year. As of the 19th of February 2026, Common Stock Shares Outstanding is likely to grow to about 33.3 M, while Capital Stock is likely to drop 2,565. . At this time, Disc Medicine's Price Book Value Ratio is very stable compared to the past year. As of the 19th of February 2026, Price To Book Ratio is likely to grow to 3.73, though Price Earnings Ratio is likely to grow to (17.49).
Disc Medicine is undervalued with Real Value of 80.97 and Target Price of 103.42. The main objective of Disc Medicine stock analysis is to determine its intrinsic value, which is an estimate of what Disc Medicine is worth, separate from its market price. There are two main types of Disc Medicine's stock analysis: fundamental analysis and technical analysis.
The Disc Medicine stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Disc Medicine is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Disc Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.

Disc Stock Analysis Notes

About 92.0% of the company shares are owned by institutional investors. The book value of Disc Medicine was currently reported as 16.38. The company recorded a loss per share of 5.37. Disc Medicine had not issued any dividends in recent years. The entity had 1:30 split on the 30th of December 2022. To learn more about Disc Medicine call Esq JD at 617 674 9274 or check out https://www.discmedicine.com.

Disc Medicine Investment Alerts

Disc Medicine generated a negative expected return over the last 90 days
Disc Medicine has high historical volatility and very poor performance
Net Loss for the year was (109.36 M) with profit before overhead, payroll, taxes, and interest of 0.
Disc Medicine generates negative cash flow from operations
Disc Medicine has a frail financial position based on the latest SEC disclosures
Over 92.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Pamela Stephenson Sells 5,531 Shares of Disc Medicine Stock

Disc Largest EPS Surprises

Earnings surprises can significantly impact Disc Medicine's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-10
2022-09-30-0.09-0.080.0111 
2024-03-21
2023-12-31-0.78-0.9-0.1215 
2023-08-11
2023-06-30-0.86-0.740.1213 
View All Earnings Estimates

Disc Medicine Environmental, Social, and Governance (ESG) Scores

Disc Medicine's ESG score is a quantitative measure that evaluates Disc Medicine's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Disc Medicine's operations that may have significant financial implications and affect Disc Medicine's stock price as well as guide investors towards more socially responsible investments.

Disc Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.48 B.

Disc Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.20)(0.21)
Return On Capital Employed(0.32)(0.30)
Return On Assets(0.20)(0.21)
Return On Equity(0.28)(0.27)

Management Efficiency

Disc Medicine has return on total asset (ROA) of (0.2261) % which means that it has lost $0.2261 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3478) %, meaning that it created substantial loss on money invested by shareholders. Disc Medicine's management efficiency ratios could be used to measure how well Disc Medicine manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of February 2026, Return On Tangible Assets is likely to drop to -0.21. In addition to that, Return On Capital Employed is likely to grow to -0.3. At this time, Disc Medicine's Total Assets are very stable compared to the past year. As of the 19th of February 2026, Other Assets is likely to grow to about 217.3 K, while Net Tangible Assets are likely to drop (60.7 M).
Last ReportedProjected for Next Year
Book Value Per Share 14.46  17.10 
Tangible Book Value Per Share 14.46  17.10 
Enterprise Value Over EBITDA(16.86)(16.02)
Price Book Value Ratio 3.55  3.73 
Enterprise Value Multiple(16.86)(16.02)
Price Fair Value 3.55  3.73 
Enterprise Value1.4 B1.5 B
The management team at Disc Medicine has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta
2.584
Return On Assets
(0.23)
Return On Equity
(0.35)

Technical Drivers

As of the 19th of February, Disc Medicine shows the Mean Deviation of 2.69, standard deviation of 4.55, and Variance of 20.72. Disc Medicine technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Disc Medicine Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.

Disc Medicine Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Disc Medicine insiders, such as employees or executives, is commonly permitted as long as it does not rely on Disc Medicine's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Disc Medicine insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Quisel John D over a week ago
Acquisition by Quisel John D of 82800 shares of Disc Medicine at 74.75 subject to Rule 16b-3
 
Khara Rahul over three weeks ago
Disposition of 1000 shares by Khara Rahul of Disc Medicine at 13.5 subject to Rule 16b-3
 
Khara Rahul over a month ago
Disposition of 6500 shares by Khara Rahul of Disc Medicine at 13.5 subject to Rule 16b-3
 
Savage William Jacob over two months ago
Disposition of 300 shares by Savage William Jacob of Disc Medicine at 92.23 subject to Rule 16b-3
 
Bitterman Kevin over two months ago
Disposition of 1371 shares by Bitterman Kevin of Disc Medicine at 93.8 subject to Rule 16b-3
 
Savage William Jacob over three months ago
Disposition of 2996 shares by Savage William Jacob of Disc Medicine at 50.0 subject to Rule 16b-3
 
Bitterman Kevin over three months ago
Disposition of 13267 shares by Bitterman Kevin of Disc Medicine at 72. subject to Rule 16b-3
 
Quisel John D over three months ago
Acquisition by Quisel John D of 10000 shares of Disc Medicine at 1.01 subject to Rule 16b-3
 
Bitterman Kevin over six months ago
Disposition of 5 shares by Bitterman Kevin of Disc Medicine at 60.95 subject to Rule 16b-3
 
Bitterman Kevin over six months ago
Disposition of 13033 shares by Bitterman Kevin of Disc Medicine at 61.17 subject to Rule 16b-3
 
Bitterman Kevin over six months ago
Disposition of 29837 shares by Bitterman Kevin of Disc Medicine at 60.97 subject to Rule 16b-3
 
Quisel John D over six months ago
Disposition of 34800 shares by Quisel John D of Disc Medicine at 9.86 subject to Rule 16b-3

Disc Medicine Outstanding Bonds

Disc Medicine issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Disc Medicine uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Disc bonds can be classified according to their maturity, which is the date when Disc Medicine has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Disc Medicine Predictive Daily Indicators

Disc Medicine intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Disc Medicine stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Disc Medicine Corporate Filings

8K
17th of February 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
13th of February 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
11th of February 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
21st of January 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
12th of January 2026
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
7th of January 2026
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
F4
5th of January 2026
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
29th of December 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Disc Medicine Forecast Models

Disc Medicine's time-series forecasting models are one of many Disc Medicine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Disc Medicine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Disc Medicine Bond Ratings

Disc Medicine financial ratings play a critical role in determining how much Disc Medicine have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Disc Medicine's borrowing costs.
Piotroski F Score
2
FrailView
Beneish M Score
(4.87)
Unlikely ManipulatorView

Disc Medicine Total Assets Over Time

Disc Medicine Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Disc Medicine uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Disc Medicine Debt Ratio

    
  6.6   
It appears that most of the Disc Medicine's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Disc Medicine's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Disc Medicine, which in turn will lower the firm's financial flexibility.

Disc Medicine Corporate Bonds Issued

Disc Medicine issues bonds to finance its operations. Corporate bonds make up one of the most significant components of the U.S. bond market and are considered the world's largest securities market. Disc Medicine uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt.

Disc Short Long Term Debt Total

Short Long Term Debt Total

36.23 Million

At this time, Disc Medicine's Short and Long Term Debt Total is very stable compared to the past year.

About Disc Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Disc Medicine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Disc shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Disc Medicine. By using and applying Disc Stock analysis, traders can create a robust methodology for identifying Disc entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Disc Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Disc analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Disc analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceConsensus# of Analysts
103.42Strong Buy11Odds
Disc Medicine current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Disc analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Disc stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Disc Medicine, talking to its executives and customers, or listening to Disc conference calls.
Disc Analyst Advice Details

Disc Stock Analysis Indicators

Disc Medicine stock analysis indicators help investors evaluate how Disc Medicine stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Disc Medicine shares will generate the highest return on investment. By understating and applying Disc Medicine stock analysis, traders can identify Disc Medicine position entry and exit signals to maximize returns.
Begin Period Cash Flow360.6 M
Long Term Debt28.3 M
Common Stock Shares Outstanding27.6 M
Total Stockholder Equity443.6 M
Total Cashflows From Investing Activities-292.3 M
Tax Provision355 K
Property Plant And Equipment Net2.3 M
Cash And Short Term Investments489.9 M
Cash192.4 M
Accounts Payable7.9 M
Net Debt-162.4 M
50 Day M A80.6344
Total Current Liabilities23.3 M
Other Operating Expenses129.7 M
Non Current Assets Total3.2 M
Non Currrent Assets Other838 K
Stock Based Compensation16.8 M
When determining whether Disc Medicine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Disc Medicine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Disc Medicine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Disc Medicine Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Disc Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Will Biotechnology sector continue expanding? Could Disc diversify its offerings? Factors like these will boost the valuation of Disc Medicine. Market participants price Disc higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Disc Medicine data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(5.37)
Return On Assets
(0.23)
Return On Equity
(0.35)
Investors evaluate Disc Medicine using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Disc Medicine's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Disc Medicine's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Disc Medicine's market price signifies the transaction level at which participants voluntarily complete trades.